SULFADIAZINE SILVER

The Defense Logistics Agency awarded a delivery order under contract SPE2DX25D8022 to Cardinal Health, Inc. (CAGE 00E55) for the supply of SULFADIAZINE SILVER, identified by NSN 6505005607331 and NDC 43598-0210-40, with a total contract value of $276.05. The award was issued on July 15, 2026, and the delivery is scheduled for the same date, with FOB DESTINATION terms placing responsibility for risk and transportation on the contractor until the item is received at the designated military destination: USNS LEROY GRUMMAN T AO 195, FPO AE 09570. The contract, governed by FAR 52.212-4 and FAR 52.212-5, classifies the item as a commercial product under FAR Part 12, with no option periods, multiple line items, or extended pricing. Packaging and handling require shipment via the fastest traceable means, explicitly excluding parcel post, and mandate detailed labeling including the manufacturer’s CAGE code, part number, contract line item number, required delivery date, document identifier code, and transportation control number to ensure compatibility with military logistics systems. No specific MIL-STDs are cited, but the labeling structure implies adherence to standard military packaging practices. Inspection and acceptance occur at the destination by an authorized government representative, with no additional technical specifications or quality standards beyond conformity to contract requirements. Payment is processed through the Defense Finance and Accounting Service in Columbus, Ohio, under Net 15 Fast Pay terms, with invoices submitted to a designated PO Box; the contractor’s remittance address is in Dublin, Ohio. The administrative contact for the contract is Catherine Gilbert of DLA Troop Support, and the contracting officer is Lorinda Ferraiolo. The order is subject to the Defense Priorities and Allocations System but lacks detailed evaluation factors, socioeconomic certifications, or personnel requirements. The parent contract ceiling of $20 million is unrelated to this specific delivery, which remains a single-line, low-value transaction focused on logistical execution and compliance with DLA’s medical supply chain protocols.